Literature DB >> 35674797

Safety of laparoscopic inguinal hernia repair in the setting of antithrombotic therapy.

Jeremy A Balch1, Dan Neal1, Cristina Crippen1, Crystal N Johnson-Mann1, Thomas E Read1, Tyler J Loftus1, Mazen R Al-Mansour2.   

Abstract

INTRODUCTION: There are a paucity of data regarding the safety of laparoscopic inguinal hernia repair in patients on antiplatelet and anticoagulant therapy (APT/ACT). We aim to compare the postoperative outcomes of laparoscopic (LIHR) vs. open repair of inguinal hernias (OIHR) in patients on APT/ACT.
METHOD: We conducted a retrospective cohort study using the Vizient Clinical DataBase. We included adults receiving APT/ACT who underwent outpatient, elective, and primary inguinal hernia repair between 2017 and 2019. Subgroup analysis was performed on patients receiving aspirin, non-aspirin antiplatelet, and anticoagulant therapy. Mixed-effects logistic regression was used to assess both the effect of APT/ACT on the probability of receiving LIHR vs OIHR and their respective outcomes. RESULT: A total of 142,052 repairs were included, of which 21,441 (15%) were performed on patients receiving APT/ACT. Mean age was 69 years (± 10.5) and 93% were male. 19% of hernias were bilateral. 40% of operations were performed at teaching hospitals. On multivariable analysis, patients on non-aspirin antiplatelet or anticoagulant therapy were more likely to receive an open procedure (Odds Ratio (OR) = 1.2; 95% Confidence Intervals (CI) [1.1, 1.4] and OR = 1.4; CI [1.3, 1.5], respectively). LIHR was associated with a lower rate of length of stay > 1 day (OR = 0.65; CI [0.5, 0.9]). Rates of 30-day postoperative hematoma, transfusions, stroke, myocardial infarction, deep venous thrombosis, pulmonary embolism, readmission, and emergency department visits were similar between the two operative approaches.
CONCLUSION: Patients on APT/ACT represent a substantial proportion of those undergoing inguinal hernia repair. Non-aspirin antiplatelet or anticoagulant therapy are independent predictors of choosing an open repair. Laparoscopic repair appears to be safe in patients receiving APT/ACT under current perioperative management patterns.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Anticoagulation; Antiplatelet; Antithrombic; Inguinal hernia repair; Laparoscopic hernia repair

Year:  2022        PMID: 35674797     DOI: 10.1007/s00464-022-09360-1

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  16 in total

1.  Laparoscopic versus open mesh repair for recurrent inguinal hernia: a meta-analysis of outcomes.

Authors:  Georgia Dedemadi; George Sgourakis; Arnold Radtke; Alexandros Dounavis; Ines Gockel; Ioannis Fouzas; Constantine Karaliotas; Evangelos Anagnostou
Journal:  Am J Surg       Date:  2010-08       Impact factor: 2.565

2.  Assessing the risk of clopidogrel-related bleeding complications in patients undergoing inguinal herniorrhaphy.

Authors:  E W Chu; D A Telem; A Chernoguz; C M Divino
Journal:  Hernia       Date:  2010-10-02       Impact factor: 4.739

3.  Under-coding of secondary conditions in coded hospital health data: Impact of co-existing conditions, death status and number of codes in a record.

Authors:  Mingkai Peng; Danielle A Southern; Tyler Williamson; Hude Quan
Journal:  Health Informatics J       Date:  2016-05-08       Impact factor: 2.681

4.  Is preoperative withdrawal of aspirin necessary in patients undergoing elective inguinal hernia repair?

Authors:  Wilson Ong; Tong Shen; Wee Boon Tan; Davide Lomanto
Journal:  Surg Endosc       Date:  2016-04-29       Impact factor: 4.584

5.  Endoscopic surgeons' preferences for inguinal hernia repair: TEP, TAPP, or OPEN.

Authors:  Salvador Morales-Conde; María Socas; Abe Fingerhut
Journal:  Surg Endosc       Date:  2012-03-22       Impact factor: 4.584

6.  Changes in Use of Anticoagulation in Patients With Atrial Fibrillation Within a Primary Care Network Associated With the Introduction of Direct Oral Anticoagulants.

Authors:  Jeffrey M Ashburner; Daniel E Singer; Steven A Lubitz; Leila H Borowsky; Steven J Atlas
Journal:  Am J Cardiol       Date:  2017-06-15       Impact factor: 2.778

7.  The safe and risk assessment of perioperative antiplatelet and anticoagulation therapy in inguinal hernia repair, a systematic review.

Authors:  Junsheng Li; Minggang Wang; Tao Cheng
Journal:  Surg Endosc       Date:  2019-07-15       Impact factor: 4.584

8.  The safety of open inguinal herniorraphy in patients on chronic warfarin therapy.

Authors:  Elisabeth C McLemore; Kristi L Harold; Stephen S Cha; Daniel J Johnson; Richard J Fowl
Journal:  Am J Surg       Date:  2006-12       Impact factor: 2.565

9.  Treatment of Inguinal Hernia: Systematic Review and Updated Network Meta-analysis of Randomized Controlled Trials.

Authors:  Alberto Aiolfi; Marta Cavalli; Simona Del Ferraro; Livia Manfredini; Gianluca Bonitta; Piero Giovanni Bruni; Davide Bona; Giampiero Campanelli
Journal:  Ann Surg       Date:  2021-12-01       Impact factor: 13.787

10.  Has endoscopic (TEP, TAPP) or open inguinal hernia repair a higher risk of bleeding in patients with coagulopathy or antithrombotic therapy? Data from the Herniamed Registry.

Authors:  F Köckerling; C Roessing; D Adolf; C Schug-Pass; D Jacob
Journal:  Surg Endosc       Date:  2015-08-15       Impact factor: 4.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.